Top-News
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?
Adial Pharmaceuticals Inc
0,6638
$
-13,6%
-13,6%
Ares Capital Corp
20,795
$
+2,24%
+2,24%
enGene Holdings [Common Shares]
3,85
$
![enGene Holdings [Common Shares] Chart](https://www.ariva.de/chart/images/chart.png?z=a179120736~b40~w170x100~Uintraday~YP0~YQ0 "enGene Holdings [Common Shares] Chart")
+3,77%
+3,77%
Neuroone Medical Technologies
0,63
$
+2,76%
+2,76%
SilverSun Technologies Inc.
-
0,00%
0,00%
NEW YORK, Dec. 5, 2023
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ADIL, ARCC, SSNT, NMTC, and ENGN.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
- ADIL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ADIL&prnumber=202312050
- ARCC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ARCC&prnumber=202312050
- SSNT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SSNT&prnumber=202312050
- NMTC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NMTC&prnumber=202312050
- ENGN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ENGN&prnumber=202312050
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-adial-pharmaceuticals-ares-capital-corp-silversun-technologies-neuroone-medical-technologies-or-engene-holdings-302006077.html
SOURCE InvestorsObserver
Für dich aus unserer Redaktion zusammengestellt
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
